• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

The obe­si­ty drug race is be­ing fought on the man­u­fac­tur­ing floor as GLP-1 ri­vals make plans to catch lead­ers

10 months ago
Pharma
In Focus

Bob Langer, Flag­ship's Stephen Beren­son to de­part Mod­er­na's board as Car­lyle co-founder joins

10 months ago
People

At Third Arc Bio, for­mer J&J lead­ers raise $165M to test on­col­o­gy, au­toim­mune bi­o­log­ics

10 months ago
Financing
Startups

Flag­ship launch­es AI-pow­ered bi­o­log­ics biotech with $50M back­ing

10 months ago
Financing
Startups

GSK says Dova­to was as ef­fec­tive as Bik­tarvy in head-to-head HIV tri­al — but pa­tients gained less weight

10 months ago
R&D

Health tech start­up Com­mure bets on AI for med­ical notes in $139M deal

10 months ago
Startups
Deals

Where Oak HC/FT in­vestor Nan­cy Brown is plac­ing her bets on AI in health tech

10 months ago
Startups
AI

WuXi AppTec more than tripled lob­by­ing spend as Biose­cure Act ad­vanced in Con­gress

10 months ago
China
Law

Blue­bird bio hand­ed neg­a­tive opin­ion from fed­er­al over­sight agency for fer­til­i­ty sup­port pro­gram

10 months ago
Pharma
FDA+

Up­dat­ed: Sam­sung wins FDA ap­proval for sec­ond Soliris biosim­i­lar

10 months ago
Pharma
FDA+

North Car­oli­na's Med­ic­aid pro­gram to cov­er weight loss drugs be­gin­ning in Au­gust

10 months ago
Pharma

Sino Bio­phar­m's in­voX to re­struc­ture, like­ly cut­ting about 60 roles

10 months ago
People

Ag­i­lent Tech­nolo­gies to ac­quire CD­MO Biovec­tra for $925M

10 months ago
Deals
Manufacturing

HI-Bio dish­es on mo­ti­va­tions for Bio­gen buy­out, cit­ing de­sire to move fast

10 months ago
Deals

Chi­nese biotech boasts com­pet­i­tive Phase 2b weight loss da­ta for GLP-1 drug

10 months ago
R&D

Grü­nen­thal inks a deal with Vali­nor; Val­ne­va gets $41M from CEPI

10 months ago
News Briefing

Lay­offs at Rapt Ther­a­peu­tics af­ter wind­ing down mid-stage tri­als of lead drug

10 months ago
People

SEC staff rec­om­mends en­force­ment ac­tion against Al­lar­i­ty over po­ten­tial fed­er­al se­cu­ri­ties laws vi­o­la­tions

10 months ago
Law

Io­n­is flash­es new An­gel­man syn­drome da­ta, will pur­sue Phase 3 tri­al next year

10 months ago
R&D

A rare dis­ease first; Lil­ly’s Alzheimer’s push; Ar­genx’s next act; No­var­tis' obe­si­ty ap­proach; and more

10 months ago
Weekly

Chi­na ap­proves Eli Lil­ly's weight loss drug as coun­try launch­es obe­si­ty aware­ness cam­paign

10 months ago
China
Pharma

Ver­mont at­tor­ney gen­er­al sues two ma­jor PBMs for al­leged­ly dri­ving up costs

10 months ago
Pharma

EMA re­asserts dif­fer­ences with FDA for Covid vac­cine strain se­lec­tion

10 months ago
FDA+
Coronavirus

US inks $113M deal with Siga to bol­ster small­pox, mpox re­serves

10 months ago
Pharma
First page Previous page 128129130131132133134 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times